Company profile OVID

Ovid Therapeutics Inc
ovid therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. ovid’s drug candidate, ov101, is currently in development for the treatment of symptoms of angelman syndrome and fragile x syndrome. ovid is also developing ov935 in collaboration with takeda pharmaceutical c...ompany limited for the treatment of rare epileptic encephalopathies. ovid has initiated the phase 2 stars trial of ov101 in adults with angelman syndrome and a phase 1 trial in adolescents with angelman and fragile x syndrome to identify doses suitable for younger patients. review our community guidelines: http://www.ovidrx.com/community-guidelines/ Show More
Quarter analysis & expected interest

There is not enough data for Ovid Therapeutics login to provide analysis

Correlation between past revenue and Ovid Therapeutics login search interest

There is not enough data for Ovid Therapeutics login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Ovid Therapeutics login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Ovid Therapeutics clinical trials to provide analysis

Correlation between past revenue and Ovid Therapeutics clinical trials search interest

There is not enough data for Ovid Therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Ovid Therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 13:20:30.

After 39 days of this quarter the interest is at 52.0. Based on that we can calculate that during remaining 52 days it will total up to 121.0.
soticlestat expected interest is significantly lower compared to previous quarter (-59.5%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201957
66
15.8% QoQ
38
-42.4% QoQ
39
2.6% QoQ
2020 83
45.6% YoY 112.8% QoQ
23
-65.2% YoY -72.3% QoQ
132
247.4% YoY 473.9% QoQ
111
184.6% YoY -15.9% QoQ
2021 222
167.5% YoY 100.0% QoQ
187
713.0% YoY -15.8% QoQ
240
81.8% YoY 28.3% QoQ
98
-11.7% YoY -59.2% QoQ
2022 100
-55.0% YoY 2.0% QoQ
188
0.5% YoY 88.0% QoQ
177
-26.2% YoY -5.9% QoQ
66
-32.7% YoY -62.7% QoQ
2023 141
41.0% YoY 113.6% QoQ
146
-22.3% YoY 3.5% QoQ
143
-19.2% YoY -2.1% QoQ
299
353.0% YoY 109.1% QoQ
2024 52
-63.1% YoY -82.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and soticlestat search interestLast update: February 09 2024 13:20:28.
Correlation coefficient between keyword and revenue is 0.72
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 13:20:32.

The average 5 years interest of soticlestat was 9.99 per week.
The last year interest of soticlestat compared to the last 5 years has changed by 36.84%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 209.28%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 13:20:37.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
OV329 expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
20190
24
inf% QoQ
83
245.8% QoQ
68
-18.1% QoQ
2020 196
inf% YoY 188.2% QoQ
26
8.3% YoY -86.7% QoQ
28
-66.3% YoY 7.7% QoQ
154
126.5% YoY 450.0% QoQ
2021 174
-11.2% YoY 13.0% QoQ
198
661.5% YoY 13.8% QoQ
27
-3.6% YoY -86.4% QoQ
0
-100.0% YoY -100.0% QoQ
2022 184
5.7% YoY inf% QoQ
54
-72.7% YoY -70.7% QoQ
143
429.6% YoY 164.8% QoQ
92
inf% YoY -35.7% QoQ
2023 137
-25.5% YoY 48.9% QoQ
98
81.5% YoY -28.5% QoQ
166
16.1% YoY 69.4% QoQ
93
1.1% YoY -44.0% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and OV329 search interestLast update: February 09 2024 13:20:36.
Correlation coefficient between keyword and revenue is 0.36
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 13:20:38.

The average 5 years interest of OV329 was 7.45 per week.
The last year interest of OV329 compared to the last 5 years has changed by 7.38%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 137.39%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for OV350 to provide analysis

Correlation between past revenue and OV350 search interest

There is not enough data for OV350 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for OV350 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for OV815 to provide analysis

Correlation between past revenue and OV815 search interest

There is not enough data for OV815 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for OV815 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for OV825 to provide analysis

Correlation between past revenue and OV825 search interest

There is not enough data for OV825 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for OV825 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for OV882 to provide analysis

Correlation between past revenue and OV882 search interest

There is not enough data for OV882 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for OV882 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 13:20:44.

After 39 days of this quarter the interest is at 87.0. Based on that we can calculate that during remaining 52 days it will total up to 203.0.
Ovid Therapeutics news expected interest is significantly higher compared to previous quarter (+76.5%) and same quarter last year (+138.8%).

YearQ1Q2Q3Q4
201919
99
421.1% QoQ
109
10.1% QoQ
80
-26.6% QoQ
2020 170
794.7% YoY 112.5% QoQ
333
236.4% YoY 95.9% QoQ
246
125.7% YoY -26.1% QoQ
147
83.8% YoY -40.2% QoQ
2021 103
-39.4% YoY -29.9% QoQ
38
-88.6% YoY -63.1% QoQ
61
-75.2% YoY 60.5% QoQ
20
-86.4% YoY -67.2% QoQ
2022 163
58.3% YoY 715.0% QoQ
0
-100.0% YoY -100.0% QoQ
175
186.9% YoY inf% QoQ
149
645.0% YoY -14.9% QoQ
2023 85
-47.9% YoY -43.0% QoQ
0
-47.9% YoY -100.0% QoQ
69
-60.6% YoY inf% QoQ
115
-22.8% YoY 66.7% QoQ
2024 87
2.4% YoY -24.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Ovid Therapeutics news search interestLast update: February 09 2024 13:20:43.
Correlation coefficient between keyword and revenue is -0.06
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 13:20:46.

The average 5 years interest of Ovid Therapeutics news was 8.69 per week.
The last year interest of Ovid Therapeutics news compared to the last 5 years has changed by -26.93%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -14.65%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 13:20:54.

After 39 days of this quarter the interest is at 24.0. Based on that we can calculate that during remaining 52 days it will total up to 56.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
20190
70
inf% QoQ
10
-85.7% QoQ
22
120.0% QoQ
2020 81
inf% YoY 268.2% QoQ
71
1.4% YoY -12.3% QoQ
74
640.0% YoY 4.2% QoQ
158
618.2% YoY 113.5% QoQ
2021 37
-54.3% YoY -76.6% QoQ
29
-59.2% YoY -21.6% QoQ
63
-14.9% YoY 117.2% QoQ
16
-89.9% YoY -74.6% QoQ
2022 42
13.5% YoY 162.5% QoQ
51
75.9% YoY 21.4% QoQ
45
-28.6% YoY -11.8% QoQ
30
87.5% YoY -33.3% QoQ
2023 88
109.5% YoY 193.3% QoQ
81
58.8% YoY -8.0% QoQ
58
28.9% YoY -28.4% QoQ
41
36.7% YoY -29.3% QoQ
2024 24
-72.7% YoY -41.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Ovid Therapeutics stock news search interestLast update: February 09 2024 13:20:52.
Correlation coefficient between keyword and revenue is -0.21
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 13:20:55.

The average 5 years interest of Ovid Therapeutics stock news was 4.18 per week.
The last year interest of Ovid Therapeutics stock news compared to the last 5 years has changed by 23.68%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 96.58%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for OVID
Earnings date: 2024-03-11 After close
Company name: Ovid Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T11:00:00Z

GlobeNewswire
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

2026-04-15T12:27:21Z

Analyst Upgrades
Wedbush Reiterates Outperform on Ovid Therapeutics, Maintains $7 Price Target

2026-04-09T11:32:39Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Ovid Therapeutics, Raises Price Target to $4

2026-04-08T12:00:00Z

GlobeNewswire
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14

2026-03-20T12:27:39Z

Analyst Upgrades
Wedbush Maintains Outperform on Ovid Therapeutics, Raises Price Target to $7

2026-02-25T12:00:00Z

GlobeNewswire
Ovid Therapeutics to Participate in Upcoming Investor Conferences

2025-12-22T15:15:56Z

Analyst Upgrades
LifeSci Capital Initiates Coverage On Ovid Therapeutics with Outperform Rating, Announces Price Target of $4

2025-12-22T11:33:08Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Ovid Therapeutics, Maintains $2 Price Target

2025-12-18T13:00:00Z

GlobeNewswire
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)

2025-12-11T12:57:02Z

Analyst Upgrades
Roth Capital Initiates Coverage On Ovid Therapeutics with Buy Rating, Announces Price Target of $3

2025-12-02T12:00:00Z

GlobeNewswire
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer

2025-11-24T11:42:05Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Ovid Therapeutics, Raises Price Target to $2

2025-11-17T12:26:27Z

Analyst Upgrades
Leerink Partners Initiates Coverage On Ovid Therapeutics with Outperform Rating, Announces Price Target of $5

2025-11-12T12:00:00Z

GlobeNewswire
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

2025-10-03T17:09:37-04:00

SEC
8-K Form - Current report, items 1.01, 3.02, 5.03, 8.01, and 9.01 - Ovid Therapeutics Inc. (0001636651) (Filer)